http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-T60434-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08ea5f246f99fd8cfc778ffd63978378
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
filingDate 1991-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8628a582e583f75ac849db816b08367e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ffbe74a73a3f6eaed3e0a481f837702
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_367431b13ec1883598bc09728a2f6acc
publicationDate 1992-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HU-T60434-A
titleOfInvention Process for producing pharmaceutical compositions comprising phebarbamate and suitable for treating diseases deriving from the breakdown or degeneration of nervous system
abstract The use of febarbamate or pharmaceutically acceptable salts for the improvement or treatment of diseases and disorders orginating in the breakdown or the degeneration of cranial, central or peripheral nerves; disorders and diseases related to the central or peripheral nervous systems; cerebrovascular disorders and neuron degeneration disorders; and/or disorders in encephalic circulation and metabolism is described. Preparation of suitable pharmaceutical compositions is also described.
priorityDate 1990-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443955
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25803
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448330950
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID318055
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4830
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448333909
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4224596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID427792045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546610
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID318055
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579328
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426080520
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66882393
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6850753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426120401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4624

Total number of triples: 47.